CDC Pathology Investigator Dies Unexpectedly at 65

Sherif Zaki worked at the Centers for Disease Control and Prevention for more than 30 years, and was renowned for uncovering crucial intel on various outbreak-causing scourges, from Ebola and Zika to SARS and influenza.

| 2 min read
Headshot of Sherif Zaki

Sherif Zaki

CDC

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Sherif Zaki, founder and chief of the Infectious Disease Pathology Branch at the Centers for Disease Control and Prevention, passed away suddenly on Sunday (November 21), according to an email sent to agency staff by National Center for Emerging and Zoonotic Infectious Diseases Director Rima Khabbaz and shared with The Scientist. The prominent pathologist, well known in the community for his work identifying pathogens at the root of various outbreaks in the US and beyond, would have turned would have turned 66 tomorrow.

Tom Ksiazek, a former CDC colleague and current professor of microbiology at the University of Texas Medical Branch’s Galveston National Laboratory, tells STAT how Zaki pioneered the use of immunohistochemistry to identify foreign proteins in samples sent to the CDC, to help determine the underlying pathogens for a particular outbreak and understand the disease they caused. According to Ksiazek, Zaki’s reputation for cracking hard cases meant that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo